StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
605033.SS$20.50+3.54%
Fair $20.50+0.0%

605033.SS

Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Basic Materials / Agricultural InputsShanghai

$20.50

+0.70 (+3.54%)

Fairly Valued+0.0%Fair Value $20.50Fund rank 35/100 · Data gapFallback financials|
SA 46/C
F-Score: 6/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $121.6M · quality 68.0/100

Data gap 35/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 59/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

46/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is 4.2%, below the 5% threshold
Thesis & Journal · 605033.SSLocal privado en este navegador · Shaanxi Meibang Pharmaceutical Group Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.8B

P/E

51.3x

↑

EV/EBITDA

30.2x

↑

ROE

4.2%

↑

Gross Margin

34.2%

↑

Debt/Equity

0.13

↓
52-Week Range$21
$17$35

TradingView lightweight chart

605033.SS price, volumen y niveles de valoración

Último $20.50Periodo +12.2%
Fair value: $20.50

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+0.2%

FCF CAGR

+37.7%

FCF margin

4.9%

FCF / Net income

0.92x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $912.0M · net income $48.7M · FCF $44.7M

2022-FY → 2025-FY

Gross margin

34.2%-8.5% pts

Operating margin

7.1%-9.5% pts

Net margin

5.3%-10.7% pts

FCF margin

4.9%+3.0% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$912.0M$912.0M$885.5M$699.0M$906.0M
Net Income$48.7M$48.7M$36.9M$57.6M$145.1M
EBITDA$85.4M$85.4M$59.6M$83.7M$168.8M
EPS0.360.360.270.431.07
Gross Margin34.2%34.2%28.5%34.2%42.7%
Operating Margin7.1%7.1%4.2%8.6%16.6%
Net Margin5.3%5.3%4.2%8.2%16.0%
Balance Sheet
Debt/Equity0.130.130.060.00—
Current Ratio2.392.39———
Cash Flow
Free Cash Flow$44.7M$44.7M$121.6M$131.1M$17.1M
Returns
ROE4.2%4.2%3.3%5.2%13.4%
Valuation
P/E51.2551.2553.8941.6016.35
EV/EBITDA30.2530.2530.0522.8812.16
P/B2.402.401.772.152.18
Growth & Yield
Revenue Growth3.0%3.0%26.7%-22.8%—
EPS Growth33.3%33.3%-37.2%-59.8%—
Dividend Yield0.9%0.9%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

71.6%

muy exigente

EPS terminal req.

$1.82

Spread vs growth

-38.3%

5Y implied EPS CAGR

43.6%

muy exigente

EPS terminal req.

$2.20

Spread vs growth

-10.3%

10Y implied EPS CAGR

25.7%

muy exigente

EPS terminal req.

$3.54

Spread vs growth

7.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +18.4%

Total return

+18.4%

Start / end P/E

64.6x → 56.9x

EPS bridge

0.27 → 0.36

Residual

-4.0%

EPS growth+33.3%
Multiple rerating-11.9%
Dividend+0.9%
Residual / FX / buybacks / cross-term-4.0%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.